Li, Qi
Kanazawa University · Kringle Pharma (Japan) · Tokushima University
2 papers on CoChatORCID 0000-0001-7380-8703
Most cited papers
- Verified
Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations
Yano, S., Wang, W., Li, Q., Matsumoto, K., Sakurama, H., Nakamura, T., Ogino, H., Kakiuchi, S., Hanibuchi, M., Nishioka, Y., et al. (2008) · Cancer Research
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 643
- Verified
Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Wang, W., Li, Q., Yamada, T., Matsumoto, K., Matsumoto, I., Oda, M., Watanabe, G., Kayano, Y., Nishioka, Y., Sone, S., et al. (2009) · Clinical Cancer Research
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 297
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free